Table 3.
Stimulation of Autophagy Was Induced by Numerous Small Molecules and Previously FDA-Approved Drugs in Various Models of HD and PD
| compd | ND model | model system | FDA-approved | other purpose | putative target/mechanism | ref |
|---|---|---|---|---|---|---|
| 5 | HD | Mammalian cell models | Y | antipsychotic | Inhibits dopaminergic D2 receptor | 57 |
| 6 | HD | Y | Blocking adrenergic and dopaminergic neural transmission (23); inhibit excitotoxicity of glutamate (25) | 57 | ||
| 7 | HD | Y | Aminergic receptors | 57 | ||
| 8 | HD | Y | Cardiac indications | Inhibitors of intracellular Ca2+ current | 57 | |
| 9 | HD | Y | 57 | |||
| 10 | HD | Y | ||||
| 11 | HD, PD | Y | Diarrhea | μ-Opioid receptor agonist; blocks Ca2+ channels in vitro cellular experiments (27, 28) | 55, 57 | |
| 12 | HD | N | Neurotoxin | Irreversible blocker of Ca2+-activated K+ channel | 57 | |
| 13 | HD, PD | Y | Hypertension | L-type Ca2+-channel antagonist | 55 | |
| 14 | HD, PD | Y | Hypertension | L-type Ca2+-channel antagonist | 55 | |
| 15 | HD, PD | Y | Sedative, hypertension | α2-adrenergic and ILR receptor agonist | 55 | |
| 16 | HD, PD | Y | Vasodilator | ATP-sensitive K+ channel agonist | 55 | |
| 17 | HD, PD | Yeast, mammalian cells, Drosophila | na | 47 | ||
| 18 | HD, PD | na | 47 | |||
| 19 | HD, PD | na | 47 | |||
| 20 | PD | Mammalian cells | na | 104 |